News
Cairo – Sandoz the global leader in generic and biosimilar medicines, today announced the introduction of its 15mg/1.5ml concentration of the OMNITROPE biosimilar growth hormone for the treatment of ...
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Proposed transaction would seamlessly align with Sandoz strategic objective of capitalizing on projected USD ...
Basel, July 30, 2025 Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announced today that it has signed a non-binding term sheet with Evotec SE. This paves the way ...
Basel, July 30, 2025 Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announced today that it has signed a non-binding term sheet with Evotec SE. This paves the ...
EQS-News: Evotec SE / Key word (s): Agreement Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site 30.07.2025 / 07:16 CET/CEST The ...
Generic and biosimilar drugmaker Sandoz has agreed to pay $265 million to settle allegations of price-fixing in a Pennsylvania lawsuit.
After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company.
Tony Chachere’s Executive Chef Gaye Sandoz, shows us her recipes for stuffed yellow squash and bacon wrapped grilled pork tenderloin! Please watch the videos to learn more about these wonderf… ...
Get the latest Sandoz Group AG (SDZNY) stock news and headlines to help you in your trading and investing decisions.
Bacterial proteases are an extensive collection of enzymes that have vital roles in cell viability, stress response and pathogenicity. Although their perturbation clearly offers the potential for ...
Medicare drug lists are available through your Part D prescription drug plan provider. However, how much you pay for the medications can vary. Read more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results